Last reviewed · How we verify
Weight loss
Approved treatments
- Victoza · Novo Nordisk
- Phenpentermine
Phenpentermine works by increasing the levels of certain neurotransmitters in the brain that help regulate appetite and metabolism. - Liraglutid · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Saxenda · Seoul National University Hospital
- Victoza · Hanmi Pharmaceutical Company Limited
- Apiquel
- Ozempic · Novo Nordisk
Semaglutide, a GLP-1 analogue, lowers blood glucose by stimulating insulin and inhibiting glucagon secretion in a glucose-dependent manner, and delays gastric emptying. - Rybelsus · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Weight loss patent landscape — cliff calendar, originator estates, attackable patents
- Weight loss treatment landscape brief
- Weight loss treatment updates RSS
Frequently asked questions about Weight loss
What drugs treat Weight loss?
Tracked treatments include Victoza, Phenpentermine, Liraglutid, Saxenda, Apiquel, Ozempic, Rybelsus.
What is the treatment for Weight loss?
Standard treatment for Weight loss includes Victoza, Phenpentermine, Liraglutid, Saxenda, Apiquel. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Weight loss patent cliff · Weight loss CI report
- Treatment: Victoza · Novo Nordisk
- Treatment: Phenpentermine
- Treatment: Liraglutid · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Treatment: Saxenda · Seoul National University Hospital
- Treatment: Victoza · Hanmi Pharmaceutical Company Limited
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing